Wenzel Katrin, Haase Hannelore, Wallukat Gerd, Derer Wolfgang, Bartel Sabine, Homuth Volker, Herse Florian, Hubner Norbert, Schulz Herbert, Janczikowski Marion, Lindschau Carsten, Schroeder Christoph, Verlohren Stefan, Morano Ingo, Muller Dominik N, Luft Friedrich C, Dietz Rainer, Dechend Ralf, Karczewski Peter
Medical Faculty of the Charité, Franz-Volhard Clinic and HELIOS Klinikum-Berlin, Experimental and Clinical Research Center, Berlin, Germany.
PLoS One. 2008;3(11):e3742. doi: 10.1371/journal.pone.0003742. Epub 2008 Nov 17.
Agonistic autoantibodies directed at the alpha(1)-adrenergic receptor (alpha(1)-AAB) have been described in patients with hypertension. We implied earlier that alpha(1)-AAB might have a mechanistic role and could represent a therapeutic target.
METHODOLOGY/PRINCIPAL FINDINGS: To pursue the issue, we performed clinical and basic studies. We observed that 41 of 81 patients with refractory hypertension had alpha(1)-AAB; after immunoadsorption blood pressure was significantly reduced in these patients. Rabbits were immunized to generate alpha(1)-adrenergic receptor antibodies (alpha(1)-AB). Patient alpha(1)-AAB and rabbit alpha(1)-AB were purified using affinity chromatography and characterized both by epitope mapping and surface plasmon resonance measurements. Neonatal rat cardiomyocytes, rat vascular smooth muscle cells (VSMC), and Chinese hamster ovary cells transfected with the human alpha(1A)-adrenergic receptor were incubated with patient alpha(1)-AAB and rabbit alpha(1)-AB and the activation of signal transduction pathways was investigated by Western blot, confocal laser scanning microscopy, and gene expression. We found that phospholipase A2 group IIA (PLA2-IIA) and L-type calcium channel (Cacna1c) genes were upregulated in cardiomyocytes and VSMC after stimulation with both purified antibodies. We showed that patient alpha(1)-AAB and rabbit alpha(1)-AB result in protein kinase C alpha activation and transient extracellular-related kinase (EKR1/2) phosphorylation. Finally, we showed that the antibodies exert acute effects on intracellular Ca(2+) in cardiomyocytes and induce mesentery artery segment contraction.
CONCLUSIONS/SIGNIFICANCE: Patient alpha(1)-AAB and rabbit alpha(1)-AB can induce signaling pathways important for hypertension and cardiac remodeling. Our data provide evidence for a potential clinical relevance for alpha(1)-AAB in hypertensive patients, and the notion of immunity as a possible cause of hypertension.
在高血压患者中已发现针对α1 - 肾上腺素能受体的激动性自身抗体(α1 - AAB)。我们之前认为α1 - AAB可能具有机制性作用,并且可能代表一个治疗靶点。
方法/主要发现:为探究该问题,我们进行了临床和基础研究。我们观察到81例难治性高血压患者中有41例存在α1 - AAB;这些患者经免疫吸附后血压显著降低。对兔子进行免疫以产生α1 - 肾上腺素能受体抗体(α1 - AB)。使用亲和色谱法纯化患者的α1 - AAB和兔子的α1 - AB,并通过表位作图和表面等离子体共振测量对其进行表征。将转染了人α1A - 肾上腺素能受体的新生大鼠心肌细胞、大鼠血管平滑肌细胞(VSMC)和中国仓鼠卵巢细胞与患者的α1 - AAB和兔子的α1 - AB一起孵育,并通过蛋白质印迹法、共聚焦激光扫描显微镜和基因表达研究信号转导通路的激活情况。我们发现,在用两种纯化抗体刺激后,心肌细胞和VSMC中的磷脂酶A2 IIA组(PLA2 - IIA)和L型钙通道(Cacna1c)基因上调。我们表明,患者的α1 - AAB和兔子的α1 - AB会导致蛋白激酶Cα激活和瞬时细胞外相关激酶(EKR1/2)磷酸化。最后,我们表明这些抗体对心肌细胞内的Ca(2+)有急性影响,并诱导肠系膜动脉段收缩。
结论/意义:患者的α1 - AAB和兔子的α1 - AB可诱导对高血压和心脏重塑重要的信号通路。我们的数据为α1 - AAB在高血压患者中的潜在临床相关性以及免疫作为高血压可能病因的观点提供了证据。